| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/15/2005 | CN1205943C Application of citrus paradisi Micf seed in preparing medicine for resisting SARS virus |
| 06/15/2005 | CN1205942C Archimycin gel for eye application |
| 06/15/2005 | CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient |
| 06/15/2005 | CN1205930C Application of matrine oxide in preparing medicine for treating nephrotic syndrome hemorrhagic fevor |
| 06/14/2005 | US6906182 Inhibiting abnormal cellular proliferation in a mammal; and a method of inhibiting replication of a virus in a mammal. |
| 06/14/2005 | US6906103 Compounds possessing antibacterial, antifungal or antitumor activity |
| 06/14/2005 | US6906090 Compositions and methods for treating mycobacterial diseases |
| 06/14/2005 | US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism |
| 06/14/2005 | US6906076 Inactivating a nuclear localization signal of a protein by contacting the protein with a compound that binds reversibly; parasiticides; viricides |
| 06/14/2005 | US6906055 Bactericides; antibiotiucs; dissolving in water, crystallization; Ceftaroline fosamil acetate |
| 06/14/2005 | US6906054 Alkylidene or dialkylidene cephalosporin-type derivatives |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906051 Viricides, fungicides, microbiocides, osteoporosis |
| 06/14/2005 | US6906042 Micelles |
| 06/14/2005 | US6906031 Polyacid glycopeptide derivatives |
| 06/14/2005 | US6905820 Polyamide nucleic acid derivatives, and agents and processes for preparing them |
| 06/14/2005 | US6905692 Suitable for topical application to skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacteria, yeasts, fungi, viruses |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents |
| 06/14/2005 | US6905455 Radioactive member and method of making |
| 06/14/2005 | CA2285463C A combination therapy for hiv infections |
| 06/14/2005 | CA2264585C Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
| 06/14/2005 | CA2098842C Use of host cell phospholipids for inhibiting microbial colonization |
| 06/09/2005 | WO2005051425A1 Procaspase 1 activation inhibitor |
| 06/09/2005 | WO2005051405A1 Il-8 production promoters and use thereof |
| 06/09/2005 | WO2005051286A2 Stable ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-yloxy) methyl)-2-amine-1h-purin-6(9h)-one. |
| 06/09/2005 | WO2005021568B1 Novel tricyclic nucleosides or nucleotides as therapeutic agents |
| 06/09/2005 | WO2005012276A3 Intermediate products of the synthesis of fluorized inhibitors of aspartic proteases |
| 06/09/2005 | WO2005009364A3 Antibiotic product, use and formulation thereof |
| 06/09/2005 | WO2003088897A3 Fab i inhibitors |
| 06/09/2005 | US20050125039 Treatment of hepatitis C using hyperthermia |
| 06/09/2005 | US20050124696 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 06/09/2005 | US20050124683 Viricides; immunomoderators |
| 06/09/2005 | US20050124677 Peptide deformylase inhibitors |
| 06/09/2005 | US20050124665 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124649 Deazapurines and uses thereof |
| 06/09/2005 | US20050124646 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 06/09/2005 | US20050124621 Novel inhibitors of kinases |
| 06/09/2005 | US20050124616 prophylaxis and treatment of herpes viral infections; e.g. N-Cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-fluorophenyl)pyrazolo[1,5-c]pyrimidin-7-amine |
| 06/09/2005 | US20050124612 E.g., 2-[2-carboxypropyl]-5-hydroxy-1,2-oxazin-3-one, more potent than desacetoxycephalosporin G; bactericides reacting irreversibly with the active site serine residue of the enzyme; enzyme inhibitors; mimetics; isocephalosporins; monocyclic beta-lactam antibiotics; antibiotic resistance |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124585 Which contain phosphoramidate linkages; for retroviral or hepadnaviral therapy; for treatment of HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 06/09/2005 | US20050124584 Prodrugs of phosphonate nucleotide analogues |
| 06/09/2005 | US20050124583 Prodrugs of phosphonate nucleotide analogues |
| 06/09/2005 | US20050124582 2-amino-6-substituted-9-[(2-hydroxymethyl or phosphatomethyl)cyclopropylidenemethyl]purines; herpes viruses, cytomegalo virus, Epstein-Barr virus, HIV |
| 06/09/2005 | US20050124579 or microbiocidal treatment of surfaces, e. g., m-octyloxybenzyl alcohol; antiseptics; preservatives; deodorization and disinfection of the skin, mucosae and hair; finishes fortextile fiber, plastics, paper, nonwovens, wood leather;washing/cleaning compounds; cosmetics; printing thickeners of starch |
| 06/09/2005 | US20050124578 Aqueous compositions containing metronidazole |
| 06/09/2005 | US20050124574 Purine derivatives |
| 06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
| 06/09/2005 | US20050124559 Antimicrobial agent |
| 06/09/2005 | US20050124540 Antigens; induce immunology response; neutralizaton antibodies; prevent infections; diagnosis |
| 06/09/2005 | US20050124536 Antifungal combination use |
| 06/09/2005 | US20050124532 Using nucleoside, or prodrug thereof |
| 06/09/2005 | US20050124064 Antimicrobial polypeptides from pseudoplectania nigrella |
| 06/09/2005 | US20050124005 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123899 Viricidal agent comprising mannose binding protein for use in directed destruction of viral particles associated with human immunodeficiency syndrome |
| 06/09/2005 | US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches |
| 06/09/2005 | US20050123636 Total coumarins include six active compounds, which have been identified as osthal, xanthotoxol xanthotoxin, isopimpinellin, bergapten, imperatorine; little side-effect |
| 06/09/2005 | US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate |
| 06/09/2005 | US20050123627 an alkalizing agent; and multiparticulates containing about 20% to 75% azithromycin, and, about 25% to 80% of a glyceride which comprises glyceryl monobehenate, glyceryl dibehenate, glyceryl tribehenate and a poloxamer |
| 06/09/2005 | US20050123617 Biodegradable polymeric nanocapsules and uses thereof |
| 06/09/2005 | US20050123612 Ribavirin granulate for producing coated tablets |
| 06/09/2005 | US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same |
| 06/09/2005 | US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids |
| 06/09/2005 | US20050123562 Novel composition |
| 06/09/2005 | US20050123561 Recombinant Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine transformed with a vector that expresses an exogenous antigenic protein; vaccine used for initial antigen stimulation in immune induction by plural antigen stimulations; prevention of infectious diseases such as HIV |
| 06/09/2005 | US20050123556 Vaccine against infectious disease |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | US20050123533 Prodrugs activated by targeted catalytic proteins |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050123511 vector comprising heterologous nucleic acid molecules that code antigenic polypeptides |
| 06/09/2005 | US20050123508 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 06/09/2005 | CA2546290A1 Depeptidized inhibitors of hepatitis c virus ns3 protease |
| 06/09/2005 | CA2546222A1 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 06/09/2005 | CA2536188A1 Electrical devices and anti-scarring agents |
| 06/09/2005 | CA2536181A1 Polymer compositions and methods for their use |
| 06/08/2005 | EP1538210A2 Dna-based vaccination of fish by immersion |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1538208A2 Mutants of streptococcal toxin A and methods of use |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1537878A1 Immunopotentiating compositions |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537868A1 Antifungal medicinal compositions |
| 06/08/2005 | EP1537861A2 Use of aminothiol compounds for the treatment xerostomia caused by therapeutic agents or radiation |
| 06/08/2005 | EP1537859A2 Azithromycin dosage forms with reduced side effects |
| 06/08/2005 | EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof |
| 06/08/2005 | EP1537226A1 Method for reproducing pleuromutilins |
| 06/08/2005 | EP1537208A1 Non-sequence complementary antiviral oligonucleotides |
| 06/08/2005 | EP1537207A2 Recombinant colstridium neurotoxin fragments |
| 06/08/2005 | EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/08/2005 | EP1537205A2 Viral deconstruction through capsid assembly in vitro |
| 06/08/2005 | EP1537203A1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 06/08/2005 | EP1537147A2 Antibody for adcc and inducing cytokine production |
| 06/08/2005 | EP1537139A2 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 06/08/2005 | EP1537123A1 Compounds |